Skip to Content
Merck
CN

Key Documents

View All Documentation

739715

Glycochenodeoxycholic-2,2,4,4-d4 acid

98 atom % D, 98% (CP)

Synonym(s):

3α,7α-Dihydroxy-5β-cholanoic-2,2,4,4-d4 acid N-(carboxymethyl)amide, N-(3α,7α-Dihydroxy-24-oxocholan-24-yl)glycine-2,2,4,4-d4, Chenodeoxycholylglycine-2,2,4,4-d4, Chenodeoxyglycocholic-2,2,4,4-d4 acid

Sign In to View Organizational & Contract Pricing.

About This Item

Empirical Formula (Hill Notation):
C26D4H39NO5
CAS Number:
1201918-16-2
Molecular Weight:
453.65
UNSPSC Code:
12352106
PubChem Substance ID:
329765375
MDL number:
MFCD03425572
Isotopic purity:
98 atom % D
Assay:
98% (CP)
Mass shift:
M+4
Form:
liquid

isotopic purity

98 atom % D

assay

98% (CP)

form

liquid

mass shift

M+4

SMILES string

[H][C@@]12[C@]([C@](CC([C@H]3O)([2H])[2H])(C)[C@@](C[C@H]2O)([H])C3([2H])[2H])([H])CC[C@@]4(C)[C@@]1([H])CC[C@]4([H])[C@]([H])(C)CCC(NCC(O)=O)=O

InChI

1S/C25H41NO6/c1-24-9-7-15(27)11-14(24)12-20(29)23-17-4-3-16(25(17,2)10-8-18(23)24)19(28)5-6-21(30)26-13-22(31)32/h14-20,23,27-29H,3-13H2,1-2H3,(H,26,30)(H,31,32)/t14-,15+,16+,17-,18-,19+,20+,23-,24-,25+/m0/s1/i7D2,11D2

InChI key

XILGPPBPXPUXQG-LXAYGWTLSA-N

Packaging

This product may be available from bulk stock and can be packaged on demand. For information on pricing, availability and packaging, please contact Stable Isotopes Customer Service.

Storage Class

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
MBBD1336
MBBC6578
MBBC2279
MBBB3615V
MBBB3566V

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Le Zhan et al.
American journal of physiology. Gastrointestinal and liver physiology, 310(2), G93-G102 (2015-11-14)
Long-term parenteral nutrition (PN) administration can lead to PN-associated liver diseases (PNALD). Although multiple risk factors have been identified for PNALD, to date, the roles of bile acids (BAs) and the pathways involved in BA homeostasis in the development and
Diana M Shih et al.
Journal of lipid research, 56(1), 22-37 (2014-11-08)
We performed silencing and overexpression studies of flavin containing monooxygenase (FMO) 3 in hyperlipidemic mouse models to examine its effects on trimethylamine N-oxide (TMAO) levels and atherosclerosis. Knockdown of hepatic FMO3 in LDL receptor knockout mice using an antisense oligonucleotide